- Home
- VYNE vs BGI Comparison
VYNE vs BGI Comparison
Compare VYNE & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- BGI
- Stock Information
- Founded
- VYNE 2003
- BGI 1879
- Country
- VYNE United States
- BGI Canada
- Employees
- VYNE N/A
- BGI N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- VYNE Health Care
- BGI
- Exchange
- VYNE Nasdaq
- BGI Nasdaq
- Market Cap
- VYNE 41.9M
- BGI 41.6M
- IPO Year
- VYNE 2018
- BGI 2005
- Fundamental
- Price
- VYNE $2.98
- BGI $1.56
- Analyst Decision
- VYNE Strong Buy
- BGI
- Analyst Count
- VYNE 2
- BGI 0
- Target Price
- VYNE $6.88
- BGI N/A
- AVG Volume (30 Days)
- VYNE 122.3K
- BGI 31.6K
- Earning Date
- VYNE 11-07-2024
- BGI 12-03-2024
- Dividend Yield
- VYNE N/A
- BGI N/A
- EPS Growth
- VYNE N/A
- BGI N/A
- EPS
- VYNE N/A
- BGI N/A
- Revenue
- VYNE $493,000.00
- BGI $136,823,177.00
- Revenue This Year
- VYNE $32.31
- BGI N/A
- Revenue Next Year
- VYNE N/A
- BGI N/A
- P/E Ratio
- VYNE N/A
- BGI N/A
- Revenue Growth
- VYNE 39.27
- BGI 13.70
- 52 Week Low
- VYNE $1.57
- BGI $1.53
- 52 Week High
- VYNE $4.09
- BGI $4.88
- Technical
- Relative Strength Index (RSI)
- VYNE 59.02
- BGI 12.50
- Support Level
- VYNE $2.65
- BGI $1.75
- Resistance Level
- VYNE $3.05
- BGI $2.19
- Average True Range (ATR)
- VYNE 0.23
- BGI 0.16
- MACD
- VYNE -0.05
- BGI -0.04
- Stochastic Oscillator
- VYNE 34.57
- BGI 11.09
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.